Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA‐Ven) or liposomal daunorubicin‐cytarabine (CPX‐351).

Details

Language :

English

ISSN :

03618609

Volume :

96

Issue :

6

Database :

Complementary Index

Journal :

American Journal of Hematology

Publication Type :

Academic Journal

Accession number :

150236942

Full Text :

https://doi.org/10.1002/ajh.26157